• Indonesia

08 Jul • Indonesia

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_tabs style=”boxed”][vc_tab title=”Updates from the Field” tab_id=”fb2a01bf-0693-2″]

[/vc_tab][vc_tab title=”Background” tab_id=”ed0cd8b8-9e78-7″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner width=”1/2″][vc_single_image image=”789″ img_size=”full” qode_css_animation=”” css=”.vc_custom_1533426076601{padding-bottom: 32px !important;}”][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text]Indonesia is missing more than 64% of its 1,020,000 people estimated to have developed drug-sensitive TB in 2016. During the same year, nearly 94% of its 32,000 people estimated to have developed drug-resistant TB were also missed by the health system.

To find more of its missing people, Indonesia is implementing a comprehensive approach to engage non-NTP providers to provide quality care and notify TB patients detected and/or treated in their service. Enhanced engagement will be ensured through strengthening the collaboration with Dirjen Yankes (Directorate General of Health Services), provider institutions, professional associations, accreditation bodies, different ministries as well as the National Health Insurance to enforce mandatory notification and comprehensive TB activities as integral part in the accreditation. Tools for enabling and enforcing mandatory notification are also being implemented. In addition, the country is training health service providers on mandatory notification and is strengthening the integration of Integrated Counselling and Testing Centres (ICTCs). Engaging more non-NTP providers is also ensured through the development of a PPM planning and referral network.

A second priority area for the country is to engage in more active TB case finding. Key components include the set-up of specimen transportation from care providers to GeneXpert MTB/RIF sites, as well as TB screening in different services of health facilities, such as diabetes mellitus patients, elderly and sick children. Indonesia is also engaging community cadres for contact tracing, with a particular focus on children and elderly populations. To adequately respond to the significantly increased need of diagnosing more people with TB, Indonesia is purchasing a further 400 GeneXpert MTB/RIF machines, along with 150 GeneXpert Omni machines for the targeted support of government-mandated community health clinics (pukesmas).[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_tab][/vc_tabs][/vc_column][/vc_row]